F. Michael (Mike) Ball is Chairman-Designate of Alcon, effective July 1, 2018.
Mr. Ball joined Alcon as CEO in February 2016 to transform its business. Previously, he was CEO of Hospira Inc. from 2011 to 2015, and president of Allergan Inc. from 2006 to 2011. Mr. Ball spent more than 15 years at Allergan in senior leadership positions and has also held roles of increasing responsibility in marketing and sales at Syntex Corporation and Eli Lilly & Co. He began his career in the healthcare industry in 1981.
Mr. Ball holds a Bachelor of Science and a Master of Business Administration from Queen’s University in Canada. He has served on the boards of several companies based in the United States, including Kythera Biopharmaceuticals Inc., Hospira, IntraLase Corp. and sTec Inc.